A Phase I Trial of SAHA (NSC 701852) and Decitabine (IND 50733, NSC 127716) in Patients With Relapsed, Refractory or Poor Prognosis Leukemia
Phase of Trial: Phase I
Latest Information Update: 04 Jan 2013
At a glance
- Drugs Decitabine (Primary) ; Vorinostat (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Biomarker
- 31 Aug 2018 Biomarkers information updated
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Oct 2008 Status changed from recruiting to active, no longer recruiting.